Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON44637
NL-OMON44637
Not Yet Recruiting
N/A

Contrast enhanced ultrasound to measure cerebral blood flow - Contrast enhanced ultrasound to measure cerebral blood flow

IC0 sites11 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsacute brain injuryacute cerebral ischemia10007963

Overview

Phase
N/A
Intervention
Not specified
Conditions
acute brain injury
Sponsor
IC
Enrollment
11
Status
Not Yet Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
IC

Eligibility Criteria

Inclusion Criteria

  • •Healthy men or women of 18\-35 years old

Exclusion Criteria

  • •\- Hypersensitivity to the active substance(s) or to any of the excipients in SonoVue
  • •\- Right\-to\-left shunt cardiac shunt
  • •\- Severe pulmonary hypertension (pulmonary artery pressure \>90 mmHg)
  • •\- Uncontrolled systemic hypertension
  • •\- Pregnancy
  • •\- Lactation
  • •\- Participation in another clinical trial within 3 months prior to the experimental day.
  • •\- History, signs, or symptoms of cardiovascular disease or pulmonary disease
  • •\- History, signs or symptoms of neurological disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Contrast enhanced ultrasound to measure cerebral blood flowacute brain injuryacute cerebral ischemia10007963
NL-OMON42396niversitair Medisch Centrum Sint Radboud10
Terminated
N/A
Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAHSubarachnoid Hemorrhage
NCT02907879Insel Gruppe AG, University Hospital Bern54
Completed
N/A
Contrast-enhanced Ultrasound (CEUS) for determining muscular Perfusion after oral intake of L-Citrulline, L-Arginine, and galloylated epicatechines.Examination of different sport supplement ingredients for their potency of vasodilation in skeletal muscle.
DRKS00016972niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie30
Withdrawn
Phase 4
Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic HydrocephalusNeonatal Post-Hemorrhagic Hydrocephalus
NCT03061045Johns Hopkins University
Recruiting
N/A
Contrast-enhanced ultrasound (CEUS) for assessment of perfusion patterns of musculoskeletal tumorsD48.9Neoplasm of uncertain or unknown behaviour, unspecified
DRKS00028080Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie300